Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
NCT01415960
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
163
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Leuprolide acetate 22.5 mg depot, GP-Pharm SA
Sponsor
GP-Pharm